title: Induction of intestinal stem cells by R-spondin 1 and Slit2 augments chemoradioprotection.
abstract: Cancer research has been rightly and successfully focused on prevention, early detection, and identification of specific molecular targets that distinguish the malignant cells from the neighbouring benign cells. However, reducing lethal tissue injury caused by intensive chemoradiotherapy during treatment of late-stage metastatic cancers remains a key clinical challenge. Here we tested whether the induction of adult stem cells could repair chemoradiation-induced tissue injury and prolong overall survival in mice. We found that intestinal stem cells (ISCs) expressed Slit2 and its single-span transmembrane cell-surface receptor roundabout 1 (Robo1). Partial genetic deletion of Robo1 decreased ISC numbers and caused villus hypotrophy, whereas a Slit2 transgene increased ISC numbers and triggered villus hypertrophy. During lethal dosages of chemoradiation, administering a short pulse of R-spondin 1 (Rspo1; a Wnt agonist) plus Slit2 reduced ISC loss, mitigated gut impairment and protected animals from death, without concomitantly decreasing tumour sensitivity to chemotherapy. Therefore Rspo1 and Slit2 may act as therapeutic adjuvants to enhance host tolerance to aggressive chemoradiotherapy for eradicating metastatic cancers.
authors.affiliation: Department of Biologic and Materials Sciences, University of Michigan School of Dentistry, Ann Arbor, Michigan 48109, USA.
authors.forename: Wei-Jie
authors.initials: WJ
authors.lastname: Zhou
authors.forename: Zhen H
authors.initials: ZH
authors.lastname: Geng
authors.forename: Jason R
authors.initials: JR
authors.lastname: Spence
authors.forename: Jian-Guo
authors.initials: JG
authors.lastname: Geng
mesh_terms: D000818:Animals; D019070:Cell Lineage; D049109:Cell Proliferation / Q000187:drug effects; D005260:Female; D006706:Homeostasis / Q000187:drug effects; D036341:Intercellular Signaling Peptides and Proteins / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D007422:Intestines / Q000166:cytology* / Q000187:drug effects / Q000473:pathology / Q000528:radiation effects; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009362:Neoplasm Metastasis / Q000188:drug therapy / Q000532:radiotherapy; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D009419:Nerve Tissue Proteins / Q000172:deficiency / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D011971:Receptors, Immunologic / Q000172:deficiency / Q000235:genetics / Q000378:metabolism; D012038:Regeneration / Q000187:drug effects / Q000528:radiation effects; D015398:Signal Transduction / Q000187:drug effects; D013234:Stem Cells / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism* / Q000528:radiation effects; D015996:Survival Rate; D019699:Thrombospondins / Q000008:administration & dosage / Q000378:metabolism* / Q000494:pharmacology; D051153:Wnt Proteins / Q000378:metabolism; D000097905:Roundabout Proteins; D000098552:Slit Homolog 2 Protein
chemical_list: D036341:Intercellular Signaling Peptides and Proteins; D009419:Nerve Tissue Proteins; D011971:Receptors, Immunologic; D019699:Thrombospondins; D051153:Wnt Proteins; D000097905:Roundabout Proteins; D000098552:Slit Homolog 2 Protein; C518903:RSPO1 protein, mouse
references.citation: Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2331-6
references.pmid: 19179402
references.citation: Nature. 2012 Aug 30;488(7413):660-4
references.pmid: 22895193
references.citation: Nature. 2011 Jul 04;476(7360):293-7
references.pmid: 21727895
references.citation: PLoS One. 2009 Nov 24;4(11):e8014
references.pmid: 19956666
references.citation: Nat Med. 2009 Jun;15(6):701-6
references.pmid: 19398967
references.citation: Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):466-71
references.pmid: 22190486
references.citation: Gastroenterology. 2012 Nov;143(5):1266-1276
references.pmid: 22841781
references.citation: Cell Stem Cell. 2011 May 6;8(5):511-24
references.pmid: 21419747
references.citation: Science. 2008 Apr 11;320(5873):226-30
references.pmid: 18403709
references.citation: Nature. 2007 Oct 25;449(7165):1003-7
references.pmid: 17934449
references.citation: J Exp Med. 2011 Feb 14;208(2):285-94
references.pmid: 21282378
references.citation: J Immunol. 2010 Nov 15;185(10):6294-305
references.pmid: 20944010
references.citation: Cell Res. 2011 Apr;21(4):609-26
references.pmid: 21283129
references.citation: Exp Cell Res. 1999 Jun 15;249(2):359-66
references.pmid: 10366435
references.citation: Nat Med. 2011 Sep 04;17(10):1225-7
references.pmid: 21892181
references.citation: J Lipid Res. 2004 Jul;45(7):1312-23
references.pmid: 15102882
references.citation: Cell. 2011 Mar 4;144(5):646-74
references.pmid: 21376230
references.citation: Nature. 2009 May 14;459(7244):262-5
references.pmid: 19329995
references.citation: Cancer Res. 1982 Oct;42(10):3964-70
references.pmid: 7104997
references.citation: Gastroenterology. 2007 Apr;132(4):1331-43
references.pmid: 17408649
references.citation: Dev Cell. 2004 May;6(5):709-17
references.pmid: 15130495
references.citation: Nat Immunol. 2007 Aug;8(8):882-92
references.pmid: 17632516
references.citation: Oncol Rep. 2010 Jan;23(1):53-9
references.pmid: 19956864
references.citation: Cancer Cell. 2003 Jul;4(1):19-29
references.pmid: 12892710
references.citation: Development. 2008 Nov;135(21):3521-30
references.pmid: 18832396
references.citation: Cell. 2012 Jun 8;149(6):1192-205
references.pmid: 22682243
references.citation: Neuron. 2004 Apr 22;42(2):213-23
references.pmid: 15091338
references.citation: Science. 2005 Aug 19;309(5738):1256-9
references.pmid: 16109882
references.citation: Exp Cell Res. 2011 Nov 15;317(19):2695-701
references.pmid: 21820431
references.citation: Nature. 2011 Feb 3;470(7332):105-9
references.pmid: 21151107